American Century Companies’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24M | Buy |
191,262
+80
| +0% | +$10.1K | 0.01% | 1003 |
|
|
2025
Q1 | $21.1M | Buy |
191,182
+98,659
| +107% | +$10.9M | 0.01% | 1014 |
|
|
2024
Q4 | $12.6M | Sell |
92,523
-88,727
| -49% | -$12.1M | 0.01% | 1246 |
|
|
2024
Q3 | $20.9M | Sell |
181,250
-17,286
| -9% | -$1.99M | 0.01% | 1004 |
|
|
2024
Q2 | $27.3M | Sell |
198,536
-28,483
| -13% | -$3.92M | 0.02% | 815 |
|
|
2024
Q1 | $31.3M | Sell |
227,019
-555,025
| -71% | -$76.5M | 0.02% | 743 |
|
|
2023
Q4 | $103M | Sell |
782,044
-231,700
| -23% | -$30.5M | 0.07% | 302 |
|
|
2023
Q3 | $114M | Sell |
1,013,744
-90,523
| -8% | -$10.2M | 0.09% | 252 |
|
|
2023
Q2 | $104M | Buy |
1,104,267
+242,362
| +28% | +$22.9M | 0.08% | 277 |
|
|
2023
Q1 | $87.2M | Buy |
861,905
+56,405
| +7% | +$5.71M | 0.07% | 301 |
|
|
2022
Q4 | $96.2M | Sell |
805,500
-238,010
| -23% | -$28.4M | 0.08% | 277 |
|
|
2022
Q3 | $111M | Sell |
1,043,510
-69,322
| -6% | -$7.36M | 0.1% | 234 |
|
|
2022
Q2 | $108M | Buy |
1,112,832
+316,984
| +40% | +$30.9M | 0.09% | 250 |
|
|
2022
Q1 | $74.6M | Buy |
795,848
+670,415
| +534% | +$62.9M | 0.05% | 353 |
|
|
2021
Q4 | $10.7M | Buy |
125,433
+6,115
| +5% | +$521K | 0.01% | 856 |
|
|
2021
Q3 | $11.4M | Sell |
119,318
-11,171
| -9% | -$1.07M | 0.01% | 808 |
|
|
2021
Q2 | $12.7M | Sell |
130,489
-15,220
| -10% | -$1.48M | 0.01% | 768 |
|
|
2021
Q1 | $14.2M | Sell |
145,709
-308
| -0.2% | -$30K | 0.01% | 710 |
|
|
2020
Q4 | $14M | Sell |
146,017
-56,578
| -28% | -$5.42M | 0.01% | 698 |
|
|
2020
Q3 | $19.5M | Sell |
202,595
-14,094
| -7% | -$1.36M | 0.02% | 541 |
|
|
2020
Q2 | $26.4M | Buy |
216,689
+58,175
| +37% | +$7.1M | 0.03% | 457 |
|
|
2020
Q1 | $13.7M | Sell |
158,514
-74,509
| -32% | -$6.45M | 0.02% | 528 |
|
|
2019
Q4 | $25M | Buy |
233,023
+6,854
| +3% | +$737K | 0.02% | 456 |
|
|
2019
Q3 | $20.4M | Buy |
226,169
+336
| +0.1% | +$30.3K | 0.02% | 489 |
|
|
2019
Q2 | $19.1M | Buy |
225,833
+40,185
| +22% | +$3.39M | 0.02% | 512 |
|
|
2019
Q1 | $16.4M | Buy |
185,648
+37,507
| +25% | +$3.3M | 0.02% | 525 |
|
|
2018
Q4 | $10.6M | Buy |
+148,141
| New | +$10.6M | 0.01% | 597 |
|
|
2018
Q3 | – | Sell |
-566,895
| Closed | -$55.7M | – | 1329 |
|
|
2018
Q2 | $55.7M | Buy |
566,895
+69,701
| +14% | +$6.85M | 0.06% | 337 |
|
|
2018
Q1 | $41.2M | Buy |
497,194
+6,546
| +1% | +$543K | 0.04% | 384 |
|
|
2017
Q4 | $38.1M | Buy |
490,648
+454,500
| +1,257% | +$35.3M | 0.04% | 421 |
|
|
2017
Q3 | $2.22M | Buy |
36,148
+2,443
| +7% | +$150K | ﹤0.01% | 1015 |
|
|
2017
Q2 | $1.55M | Buy |
33,705
+886
| +3% | +$40.7K | ﹤0.01% | 1075 |
|
|
2017
Q1 | $1.42M | Sell |
32,819
-277,416
| -89% | -$12M | ﹤0.01% | 1094 |
|
|
2016
Q4 | $12M | Sell |
310,235
-570,272
| -65% | -$22.1M | 0.01% | 628 |
|
|
2016
Q3 | $44.6M | Buy |
880,507
+58,980
| +7% | +$2.99M | 0.05% | 378 |
|
|
2016
Q2 | $37.3M | Buy |
821,527
+738,598
| +891% | +$33.6M | 0.04% | 421 |
|
|
2016
Q1 | $3.28M | Sell |
82,929
-2,478
| -3% | -$98K | ﹤0.01% | 914 |
|
|
2015
Q4 | $4.83M | Buy |
85,407
+6,264
| +8% | +$354K | 0.01% | 844 |
|
|
2015
Q3 | $3.15M | Buy |
79,143
+38,079
| +93% | +$1.52M | ﹤0.01% | 953 |
|
|
2015
Q2 | $1.96M | Sell |
41,064
-10,706
| -21% | -$511K | ﹤0.01% | 1031 |
|
|
2015
Q1 | $2.06M | Sell |
51,770
-9,487
| -15% | -$377K | ﹤0.01% | 1043 |
|
|
2014
Q4 | $1.37M | Sell |
61,257
-4,881
| -7% | -$109K | ﹤0.01% | 1148 |
|
|
2014
Q3 | $1.04M | Buy |
66,138
+3,174
| +5% | +$49.7K | ﹤0.01% | 1176 |
|
|
2014
Q2 | $934K | Buy |
62,964
+204
| +0.3% | +$3.03K | ﹤0.01% | 1231 |
|
|
2014
Q1 | $1.01M | Buy |
+62,760
| New | +$1.01M | ﹤0.01% | 1223 |
|
|
2013
Q4 | – | Sell |
-62,278
| Closed | -$705K | – | 1474 |
|
|
2013
Q3 | $705K | Buy |
62,278
+3,830
| +7% | +$43.4K | ﹤0.01% | 1299 |
|
|
2013
Q2 | $782K | Buy |
+58,448
| New | +$782K | ﹤0.01% | 1252 |
|